Literature DB >> 18476174

Ethical dimensions of human immunodeficiency virus infection during pregnancy.

F A Chervenak1, L B McCullough, W J Ledger.   

Abstract

Physicians encounter complex and sensitive ethical challenges in the medical care of pregnant women with human immunodeficiency virus (HIV) infection. This paper identifies those ethical challenges and provides concrete clinical guidance for how they should be addressed in obstetric care. The paper begins with a brief historical review, to highlight and to call into question the civil rights model of the ethics of HIV infection that has dominated the literature, clinical practice, and public policy. The authors propose an alternative ethical framework. This framework begins by underscoring the public health obligations of both physicians and pregnant women with HIV infection. The framework is based on a clinical ethics that appeals to both beneficence-based and autonomy-based obligations of the physician to the pregnant woman and the beneficence-based obligations of both the physician and the pregnant woman to the fetal patient. This framework is then deployed in a clinical ethical analysis of termination of pregnancy and contraception, partner notification, disclosure and confidentiality of her serostatus by the patient to the health care team, disclosure and confidentiality of her serostatus to other health care professionals, prevention of vertical transmission, and advance directives.

Entities:  

Year:  1997        PMID: 18476174      PMCID: PMC2364565          DOI: 10.1155/S106474499700029X

Source DB:  PubMed          Journal:  Infect Dis Obstet Gynecol        ISSN: 1064-7449


  7 in total

Review 1.  The Americans with Disabilities Act: I. History, summary, and key components.

Authors:  D Essex-Sorlie
Journal:  Acad Med       Date:  1994-07       Impact factor: 6.893

2.  The Medical Directive. A new comprehensive advance care document.

Authors:  L L Emanuel; E J Emanuel
Journal:  JAMA       Date:  1989-06-09       Impact factor: 56.272

3.  A comparison of immediate with deferred zidovudine therapy for asymptomatic HIV-infected adults with CD4 cell counts of 500 or more per cubic millimeter. AIDS Clinical Trials Group.

Authors:  P A Volberding; S W Lagakos; J M Grimes; D S Stein; J Rooney; T C Meng; M A Fischl; A C Collier; J P Phair; M S Hirsch
Journal:  N Engl J Med       Date:  1995-08-17       Impact factor: 91.245

Review 4.  Care of women infected with the human immunodeficiency virus.

Authors:  H L Minkoff; J A DeHovitz
Journal:  JAMA       Date:  1991 Oct 23-30       Impact factor: 56.272

5.  Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. Pediatric AIDS Clinical Trials Group Protocol 076 Study Group.

Authors:  E M Connor; R S Sperling; R Gelber; P Kiselev; G Scott; M J O'Sullivan; R VanDyke; M Bey; W Shearer; R L Jacobson
Journal:  N Engl J Med       Date:  1994-11-03       Impact factor: 91.245

Review 6.  Policy, ethics, and reproductive choice: pregnancy and childbearing among HIV-infected women.

Authors:  N E Kass
Journal:  Acta Paediatr Suppl       Date:  1994-08

7.  The values history. The evaluation of the patient's values and advance directives.

Authors:  D J Doukas; L B McCullough
Journal:  J Fam Pract       Date:  1991-02       Impact factor: 0.493

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.